Article
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.
The Biochemical journal - 15 Sept 2010
Nichols R Jeremy, Dzamko Nicolas, Morrice Nicholas A, Campbell David G, Deak Maria, Ordureau Alban, Macartney Thomas, Tong Youren, Shen Jie, Prescott Alan R, Alessi Dario R
Abstract excerpt
LRRK2 (leucine-rich repeat protein kinase 2) is mutated in a significant number of Parkinson's disease patients, but still little is understood about how it is regulated or functions. In the present study we have demonstrated that 14-3-3 protein isoforms interact with LRRK2. Consistent with this, endogenous LRRK2 isolated from Swiss 3T3 cells or various mouse tissues is associated with endogenous 14-3-3 isoforms....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
